MedTechnology
By
Is NVIDIA Powering the AI Revolution in Medical Diagnostics as Healthcare Partners Commit to Next‑Gen Intelligence Platforms?
Executive Summary NVIDIA, the global leader in accelerated computing and AI infrastructure, is increasingly at the core of…
Does BioMark’s 2025 Corporate Update Mark the Shift from Clinical Validation to Commercial-Scale Growth in Lung Cancer Diagnostics?
Executive Summary BioMark’s 2025 corporate update marks a decisive inflection point as the company completes a landmark lung…
Can AI-Automated Hematology Redefine Laboratory Diagnostics? WORK Medical Secures Manufacturing Approval for Class II Blood Cell Analyzer
Hangzhou, China – December 2025 — WORK Medical Technology Group LTD (Nasdaq: WOK) today announced that its subsidiary,…
Is McRae Tech Setting a New Standard for Scalable AI in Healthcare with Its Orchestral Platform?
McRae Tech has introduced Orchestral, a health-focused AI orchestrator data platform designed to support large-scale, governed use of…
Is China Becoming a Power Center for AI-Led Drug Discovery? Insilico Medicine Strikes $66 Million NLRP3 Licensing Deal
23 January 2026 Executive Summary Artificial-intelligence-driven drug developer Insilico Medicine has entered into a $66 million licensing agreement…
Is the U.S. Reopening the Door to Coverage Losses? ACA Subsidy Expiration Fuels Cost and Enrollment Uncertainty
23 January 2026 Executive Summary The expiration of enhanced Affordable Care Act (ACA) subsidies is continuing to drive…
